Target intelligence / Profile preview

Actin gamma 1 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

The actin, gamma 1 pseudogene (ENSG00000249878, LOC643307) is a non-protein-coding sequence in the human genome that is homologous to ACTG1, the gene encoding cytoplasmic actin gamma 1. Unlike the protein-coding ACTG1 gene, this pseudogene does not produce a functional actin protein and has no established cellular roles. Pseudogenes often arise from gene duplication or retrotransposition events, and while they may sometimes serve regulatory functions (such as generation of non-coding RNAs), there is no evidence of such a role for this locus. ACTG1 (not this pseudogene) is the gene relevant for hearing, cytoskeletal disorders, and certain cancers[1][2][3]. This pseudogene should not be mistaken for ACTG1, the protein-coding gene with clinical and therapeutic relevance. Key distinction: If you are seeking information about the cytoskeletal protein or a pharmaceutically relevant target, you should refer to the protein-coding gene ACTG1 (Ensembl: ENSG00000184009), not this pseudogene[2][3]. The current entry is not a valid therapeutic or functional molecular target.

Other names
LOC643307actin, gamma 1 pseudogeneACTG1P

Beyond the preview

Go deeper on Actin gamma 1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin gamma 1 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call